Literature DB >> 28653373

Association between Parkinson's disease and diabetes: Data from NEDICES study.

E De Pablo-Fernandez1, F Sierra-Hidalgo2,3, J Benito-León3,4,5, F Bermejo-Pareja3,4,5.   

Abstract

BACKGROUND: Despite growing evidence showing an association between Parkinson's disease (PD) and diabetes, epidemiological studies have shown conflicting results. AIMS OF THE STUDY: To evaluate the association between PD and diabetes and the impact of diabetes duration in this association in an elderly (≥65 years) Spanish population.
METHODS: Data for this cross-sectional population-based analysis were obtained from NEDICES study. Subjects were identified from census list. Diagnosis of PD was confirmed by neurological examination. Diabetes was defined by self-report, being on antidiabetic medication or diagnosis on medical records. Logistic regression analysis adjusted by potential confounders was performed to estimate the association between both conditions and also after dividing patients into short-duration (<10 years) and long-duration (≥10 years) diabetes.
RESULTS: A total of 4998 subjects were included (79 PD and 4919 controls). Univariate analysis did not show any association between prevalence of PD and diabetes (OR 1.89, 95% CI 0.90-3.98, P=.09), although subgroup analysis showed a positive association in those with long-duration diabetes (3.27, 95% CI 1.21-8.85, P=.02).
CONCLUSIONS: Diabetes duration might be an important factor in the association between PD and diabetes, and the risk might be limited to those with longer disease duration.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Parkinson's disease; cross-sectional study; diabetes mellitus; neurodegeneration; neuroepidemiology

Mesh:

Year:  2017        PMID: 28653373     DOI: 10.1111/ane.12793

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  17 in total

Review 1.  Na+ leak-current channel (NALCN) at the junction of motor and neuropsychiatric symptoms in Parkinson's disease.

Authors:  Merve Kasap; Donard S Dwyer
Journal:  J Neural Transm (Vienna)       Date:  2021-05-07       Impact factor: 3.575

2.  Metabolism and memory: α-synuclein level in children with obesity and children with type 1 diabetes; relation to glucotoxicity, lipotoxicity and executive functions.

Authors:  Nouran Yousef Salah; Sara Ibrahim Taha; Safeya Hassan; Mai Seif ElDin Abdeen; Mostafa Ahmad Hashim; Rana Mahmoud
Journal:  Int J Obes (Lond)       Date:  2022-09-24       Impact factor: 5.551

Review 3.  Epidemiological Evidence for an Immune Component of Parkinson's Disease.

Authors:  Paulina Gonzalez-Latapi; Connie Marras
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 4.  Targeting energy metabolism via the mitochondrial pyruvate carrier as a novel approach to attenuate neurodegeneration.

Authors:  Emmanuel Quansah; Wouter Peelaerts; J William Langston; David K Simon; Jerry Colca; Patrik Brundin
Journal:  Mol Neurodegener       Date:  2018-05-24       Impact factor: 14.195

5.  Association Between Glycemic Status and the Risk of Parkinson Disease: A Nationwide Population-Based Study.

Authors:  Sang Youl Rhee; Kyung-Do Han; Hyemi Kwon; Se-Eun Park; Yong-Gyu Park; Yang-Hyun Kim; Soon-Jip Yoo; Eun-Jung Rhee; Won-Young Lee
Journal:  Diabetes Care       Date:  2020-07-01       Impact factor: 19.112

Review 6.  Shared (epi)genomic background connecting neurodegenerative diseases and type 2 diabetes.

Authors:  Valerio Caputo; Andrea Termine; Claudia Strafella; Emiliano Giardina; Raffaella Cascella
Journal:  World J Diabetes       Date:  2020-05-15

Review 7.  Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson's Disease: A Systematic Review.

Authors:  Fauze Camargo Maluf; David Feder; Alzira Alves de Siqueira Carvalho
Journal:  Parkinsons Dis       Date:  2019-11-23

Review 8.  Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson's Disease.

Authors:  Annekatrin König; Hugo Vicente Miranda; Tiago Fleming Outeiro
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

Review 9.  The Association Between Type 2 Diabetes Mellitus and Parkinson's Disease.

Authors:  Julia L Y Cheong; Eduardo de Pablo-Fernandez; Thomas Foltynie; Alastair J Noyce
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

10.  Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's disease.

Authors:  Shuchun Chen; Seong-Jin Yu; Yazhou Li; Daniela Lecca; Elliot Glotfelty; Hee Kyung Kim; Ho-Il Choi; Barry J Hoffer; Nigel H Greig; Dong Seok Kim; Yun Wang
Journal:  Sci Rep       Date:  2018-07-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.